Companies will partner to advance small molecules in up to six discrete projects, including three existing programs against specific predetermined targets
Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials.